362 related articles for article (PubMed ID: 33231569)
21. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 receptor and malignant cancers: Association of
Zhang L; Wei C; Li D; He J; Liu S; Deng H; Cheng J; Du J; Liu X; Chen H; Sun S; Yu H; Fu J
Int J Biol Sci; 2022; 18(6):2362-2371. PubMed ID: 35414771
[TBL] [Abstract][Full Text] [Related]
23. Effects of vitamin C and D on the mRNA expression of angiotensin converting enzyme 2 receptor, cathepsin L, and transmembrane serine protease in the mouse lungs.
A Alruwaili M; Jarrar Y
Libyan J Med; 2022 Dec; 17(1):2054111. PubMed ID: 35311495
[TBL] [Abstract][Full Text] [Related]
24. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Zhang Z; Li L; Li M; Wang X
Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
[TBL] [Abstract][Full Text] [Related]
25. Colorectal Cancer that Highly Express Both
Wang H; Yang J
Pathol Oncol Res; 2021; 27():612969. PubMed ID: 34257580
[TBL] [Abstract][Full Text] [Related]
26. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
28. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
Prasad K; AlOmar SY; Almuqri EA; Rudayni HA; Kumar V
PLoS One; 2021; 16(8):e0256141. PubMed ID: 34407143
[TBL] [Abstract][Full Text] [Related]
29. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.
Kwan JYY; Lin LT; Bell R; Bruce JP; Richardson C; Pugh TJ; Liu FF
Sci Rep; 2021 Feb; 11(1):4533. PubMed ID: 33633121
[TBL] [Abstract][Full Text] [Related]
30. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
Sakamoto A; Kawakami R; Kawai K; Gianatti A; Pellegrini D; Kutys R; Guo L; Mori M; Cornelissen A; Sato Y; Bellasi A; Faggi L; Hong C; Romero M; Guagliumi G; Virmani R; Finn AV
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):542-544. PubMed ID: 33086866
[No Abstract] [Full Text] [Related]
31. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma.
Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J
Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.
Rehman SU; Tabish M
Clin Sci (Lond); 2020 May; 134(10):1143-1150. PubMed ID: 32442315
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
[TBL] [Abstract][Full Text] [Related]
34. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.
Hassan SS; Ghosh S; Attrish D; Choudhury PP; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Uversky VN; Seyran M; Pizzol D; Adadi P; Soares A; El-Aziz TMA; Kandimalla R; Tambuwala MM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Á; Chauhan G; Palu G; Brufsky AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322198
[TBL] [Abstract][Full Text] [Related]
35. Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Chen L; Liu Y; Wu J; Deng C; Tan J; Liu H; Zhong L
Aging (Albany NY); 2021 Jan; 13(2):1620-1632. PubMed ID: 33429366
[TBL] [Abstract][Full Text] [Related]
36. The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma.
Gao F; Wang X; Qin N; Zhang M; Liao M; Zeng M; Lu D; Sha O
Front Immunol; 2023; 14():1156038. PubMed ID: 37292206
[TBL] [Abstract][Full Text] [Related]
37. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.
Smieszek SP; Przychodzen BP; Polymeropoulos MH
Int J Antimicrob Agents; 2020 Jun; 55(6):106004. PubMed ID: 32361028
[TBL] [Abstract][Full Text] [Related]
38. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
39. The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer.
Jiang Y; Chen L; Shen J; Mei X; Yao J; Chen T; Zhou Y
Aging (Albany NY); 2021 Aug; 13(17):20886-20895. PubMed ID: 34413267
[TBL] [Abstract][Full Text] [Related]
40. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
